Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cell therapy in cardiovascular disease
2014-000078-21Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jun 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous mesenchymal stem cells in cardiac morbidity, sponsored by Centre hospitalier universitaire de Toulouse. Started Jun 2015; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2014-000078-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000078-21.